Huaimin W. Liu

No. 127 Dongming Road
Zhengzhou, 450008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Immunosuppressive cells as barriers to cancer therapy: mechanisms and emerging solutions.

Immunosuppressive cells as barriers to cancer therapy: mechanisms and emerging solutions.

Journal: Frontiers in immunology

Published: May 31, 2026

Inhibition of RAB7 promotes CD8+ T cell activation via the STING/IRF1/CCL5/CXCL10 signaling axis to promote PD-1-mediated anti-lung cancer efficacy.

Inhibition of RAB7 promotes CD8+ T cell activation via the STING/IRF1/CCL5/CXCL10 signaling axis to promote PD-1-mediated anti-lung cancer efficacy.

Journal: American journal of cancer research

Published: December 03, 2025

Canregtools: a tool package for routine statistical analysis of Chinese population-based cancer registry data based on R language

Canregtools: a tool package for routine statistical analysis of Chinese population-based cancer registry data based on R language

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: November 25, 2025

Case Report: A patient harboring rare EGFR S768I/V769L compound mutation benefited from afatinib and osimertinib.

Case Report: A patient harboring rare EGFR S768I/V769L compound mutation benefited from afatinib and osimertinib.

Journal: Frontiers in pharmacology

Published: September 27, 2025

Therapeutic potential of inosine in acute lung injury: mechanistic insights into TLR4 suppression and macrophage polarization.

Therapeutic potential of inosine in acute lung injury: mechanistic insights into TLR4 suppression and macrophage polarization.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: February 26, 2025

Effects of chemotherapy combined with immunotherapy for non-small cell lung cancer with BRAF-mutations: a retrospective study.

Effects of chemotherapy combined with immunotherapy for non-small cell lung cancer with BRAF-mutations: a retrospective study.

Journal: American journal of cancer research

Published: January 07, 2025

RE: Long-term survival across Breslow thickness categories: findings from a population-based study of 210 042 Australian melanoma patients.

RE: Long-term survival across Breslow thickness categories: findings from a population-based study of 210 042 Australian melanoma patients.

Journal: Journal of the National Cancer Institute

Published: January 06, 2025

Peripheral B-cell levels predict efficacy and overall survival in advanced melanoma patients under PD-1 immunotherapy.

Peripheral B-cell levels predict efficacy and overall survival in advanced melanoma patients under PD-1 immunotherapy.

Journal: Immunotherapy

Published: December 21, 2023

PANoptosis: Mechanisms, biology, and role in disease.

PANoptosis: Mechanisms, biology, and role in disease.

Journal: Immunological reviews

Published: August 30, 2023

Nanodrugs systems for therapy and diagnosis of esophageal cancer.

Nanodrugs systems for therapy and diagnosis of esophageal cancer.

Journal: Frontiers in bioengineering and biotechnology

Published: June 02, 2023

Akkermansia muciniphila inhibits tryptophan metabolism via the AhR/β-catenin signaling pathway to counter the progression of colorectal cancer.

Akkermansia muciniphila inhibits tryptophan metabolism via the AhR/β-catenin signaling pathway to counter the progression of colorectal cancer.

Journal: International journal of biological sciences

Published: April 28, 2023

Prognostic significance of baseline peripheral blood lymphocyte subsets on second-line immunotherapy in advanced esophageal squamous cell carcinoma.

Prognostic significance of baseline peripheral blood lymphocyte subsets on second-line immunotherapy in advanced esophageal squamous cell carcinoma.

Journal: Asian journal of surgery

Published: March 02, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026